{"filing":{"accession_number":"0001193125-26-261716","cik":"0001768446","ticker":"CLYM","company_name":"Climb Bio, Inc.","form":"8-K","filing_date":"2026-06-08","report_date":null,"primary_document":"d72849d8k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1768446/000119312526261716/d72849d8k.htm"},"events":[{"id":6199,"run_id":5443,"accession_number":"0001193125-26-261716","anchor_item_number":"5.07","event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"summary":"Climb Bio held its Annual Meeting of stockholders on June 8, 2026, with voting results on multiple proposals: election of directors Alexander Cumbo and Douglas Williams, ratification of PricewaterhouseCoopers LLP as auditor, rejection of a director removal for cause amendment, and approval of the 2021 Equity Incentive Plan Amendment to include prefunded warrants in the automatic share pool increase mechanism.","company_name":"Climb Bio, Inc.","ticker":"CLYM","filing_date":"2026-06-08","form":"8-K","submitted_at":null,"items":[{"id":5192,"accession_number":"0001193125-26-261716","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of an amendment to the 2021 Equity Incentive Plan that modifies the automatic share pool increase mechanism to include prefunded warrants. This is a compensatory arrangement amendment affecting equity grants and incentive plan mechanics, which falls squarely within exec_compensation. The amendment is material as it affects the pool of shares available for executive and employee compensation.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T20:10:08.862684+00:00","company_name":"","ticker":null,"filing_date":""},{"id":5193,"accession_number":"0001193125-26-261716","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This Item 5.07 disclosure reports the results of Climb Bio's Annual Meeting of stockholders, including election of two directors (Alexander Cumbo and Douglas Williams), ratification of PricewaterhouseCoopers LLP as auditor, a failed amendment proposal regarding director removal for cause, and approval of the 2021 Plan Amendment. The filing presents voting tallies for each proposal, which is the core content of a shareholder vote results disclosure. Director elections and auditor ratification are material governance matters affecting investor assessment of board composition and financial oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T20:10:08.862684+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":5192,"accession_number":"0001193125-26-261716","item_number":"5.02","item_title":null,"event_type":"exec_compensation","event_domain":"governance","is_material":true,"confidence":0.92,"reasoning":"The disclosure centers on stockholder approval of an amendment to the 2021 Equity Incentive Plan that modifies the automatic share pool increase mechanism to include prefunded warrants. This is a compensatory arrangement amendment affecting equity grants and incentive plan mechanics, which falls squarely within exec_compensation. The amendment is material as it affects the pool of shares available for executive and employee compensation.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T20:10:08.862684+00:00","company_name":"Climb Bio, Inc.","ticker":"CLYM","filing_date":"2026-06-08"},{"id":5193,"accession_number":"0001193125-26-261716","item_number":"5.07","item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.95,"reasoning":"This Item 5.07 disclosure reports the results of Climb Bio's Annual Meeting of stockholders, including election of two directors (Alexander Cumbo and Douglas Williams), ratification of PricewaterhouseCoopers LLP as auditor, a failed amendment proposal regarding director removal for cause, and approval of the 2021 Plan Amendment. The filing presents voting tallies for each proposal, which is the core content of a shareholder vote results disclosure. Director elections and auditor ratification are material governance matters affecting investor assessment of board composition and financial oversight.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-08T20:10:08.862684+00:00","company_name":"Climb Bio, Inc.","ticker":"CLYM","filing_date":"2026-06-08"}]}